{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:44:43Z","timestamp":1786985083507,"version":"build-2736575974"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100003185","name":"National Psoriasis Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100003185","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005026","name":"Foundation Against Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"FWO","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004385","name":"Ghent University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004385","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.bcp.2024.116316","type":"journal-article","created":{"date-parts":[[2024,5,24]],"date-time":"2024-05-24T18:57:33Z","timestamp":1716577053000},"page":"116316","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Polo-like kinase 1 (PLK1) is a novel CARD14-binding protein in keratinocytes"],"prefix":"10.1016","volume":"228","author":[{"given":"Styliani","family":"Iliaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marja","family":"Kreike","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Ferreras Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Femke","family":"De Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aigerim","family":"Aidarova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harald","family":"Braun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claude","family":"Libert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inna S.","family":"Afonina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5704-582X","authenticated-orcid":false,"given":"Rudi","family":"Beyaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2024.116316_b0005","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.3389\/fimmu.2018.02167","article-title":"CARD14\/CARMA2 Signaling and its Role in Inflammatory Skin Disorders","volume":"9","author":"Zotti","year":"2018","journal-title":"Front Immunol."},{"key":"10.1016\/j.bcp.2024.116316_b0010","doi-asserted-by":"crossref","first-page":"914","DOI":"10.15252\/embr.201642109","article-title":"The paracaspase MALT1 mediates CARD14-induced signaling in keratinocytes","volume":"17","author":"Afonina","year":"2016","journal-title":"EMBO Rep."},{"key":"10.1016\/j.bcp.2024.116316_b0015","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1042\/BCJ20160270","article-title":"Psoriasis mutations disrupt CARD14 autoinhibition promoting BCL10-MALT1-dependent NF-\u03baB activation","volume":"473","author":"Howes","year":"2016","journal-title":"Biochem J."},{"key":"10.1016\/j.bcp.2024.116316_b0020","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jaci.2018.09.002","article-title":"Loss-of-function mutations in caspase recruitment domain-containing protein 14 (CARD14) are associated with a severe variant of atopic dermatitis","volume":"143","author":"Peled","year":"2019","journal-title":"J Allergy Clin Immunol."},{"key":"10.1016\/j.bcp.2024.116316_b0025","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1002\/jcp.29161","article-title":"CARD14\/CARMA2sh and TANK differentially regulate poly(I:C)-induced inflammatory reaction in keratinocytes","volume":"235","author":"Voccola","year":"2020","journal-title":"J Cell Physiol."},{"key":"10.1016\/j.bcp.2024.116316_b0030","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.immuni.2018.05.012","article-title":"Gain-of-Function Mutation of Card14 Leads to Spontaneous Psoriasis-like Skin Inflammation through Enhanced Keratinocyte Response to IL-17A","volume":"49","author":"Wang","year":"2018","journal-title":"Immunity."},{"key":"10.1016\/j.bcp.2024.116316_b0035","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.jid.2015.12.027","article-title":"MALT1 Protease Activity Controls the Expression of Inflammatory Genes in Keratinocytes upon Zymosan Stimulation","volume":"136","author":"Schmitt","year":"2016","journal-title":"J Invest Dermatol."},{"key":"10.1016\/j.bcp.2024.116316_b0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7554\/eLife.56720","article-title":"CARD14 E138A signaling in keratinocytes induces TNF-dependent skin and systemic inflammation","volume":"9","author":"Manils","year":"2020","journal-title":"Elife."},{"key":"10.1016\/j.bcp.2024.116316_b0045","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1016\/j.jid.2018.03.1525","article-title":"CARD14 Gain-of-Function Mutation Alone Is Sufficient to Drive IL-23 \/ IL-17-Mediated Psoriasiform Skin Inflammation In Vivo","volume":"138","author":"Mellett","year":"2018","journal-title":"J Invest Dermatol."},{"key":"10.1016\/j.bcp.2024.116316_b0050","first-page":"110:104286","article-title":"Gain of function p. E138A alteration in Card14 leads to psoriasiform skin inflammation and implicates genetic modifiers in disease severity","author":"Sundberg","year":"2019","journal-title":"Exp Mol Pathol."},{"key":"10.1016\/j.bcp.2024.116316_b0055","doi-asserted-by":"crossref","first-page":"e49237","DOI":"10.15252\/embr.201949237","article-title":"MALT1 targeting suppresses CARD14-induced psoriatic dermatitis in mice","volume":"21","author":"Van Nuffel","year":"2020","journal-title":"EMBO Rep."},{"key":"10.1016\/j.bcp.2024.116316_b0060","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1002\/jcp.22667","article-title":"Alternative Splicing of CARMA2 \/ CARD14 Transcripts Generates Protein Variants With Differential Effect on NF-kB Activation and Endoplasmic Reticulum Stress-Induced Cell Death","volume":"226","author":"Scudiero","year":"2011","journal-title":"J Cell Physiol."},{"key":"10.1016\/j.bcp.2024.116316_b0065","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.3389\/fimmu.2018.01927","article-title":"Holding All the CARDs: How MALT1 Controls CARMA\/CARD-Dependent Signaling","volume":"9","author":"Juilland","year":"2018","journal-title":"Front Immunol."},{"key":"10.1016\/j.bcp.2024.116316_b0070","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.immuni.2005.09.014","article-title":"Phosphorylation of the CARMA1 linker controls NF-kappaB activation","volume":"23","author":"Sommer","year":"2005","journal-title":"Immunity."},{"key":"10.1016\/j.bcp.2024.116316_b0075","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1111\/febs.15522","article-title":"Defining the combinatorial space of PKC::CARD-CC signal transduction nodes","volume":"288","author":"Staal","year":"2021","journal-title":"FEBS J."},{"key":"10.1016\/j.bcp.2024.116316_b0080","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1111\/febs.17035","article-title":"Chimeric and mutant CARD9 constructs enable analyses of conserved and diverged autoinhibition mechanisms in the CARD-CC protein family","volume":"291","author":"Staal","year":"2023","journal-title":"FEBS J."},{"key":"10.1016\/j.bcp.2024.116316_b0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114747","article-title":"Polo-like kinase 1 (PLK1) signaling in cancer and beyond","volume":"193","author":"Iliaki","year":"2021","journal-title":"Biochem Pharmacol."},{"key":"10.1016\/j.bcp.2024.116316_b0090","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1083\/jcb.106.3.761","article-title":"Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line","volume":"106","author":"Boukamp","year":"1988","journal-title":"J Cell Biol."},{"key":"10.1016\/j.bcp.2024.116316_b0095","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1038\/nbt.1511","article-title":"MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification","volume":"26","author":"Cox","year":"2008","journal-title":"Nat Biotechnol."},{"key":"10.1016\/j.bcp.2024.116316_b0100","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1074\/mcp.M113.031591","article-title":"Accurate proteome-wide label-free quantification by delayed normalization and maximal peptide ratio extraction, termed MaxLFQ","volume":"13","author":"Cox","year":"2014","journal-title":"Mol Cell Proteomics."},{"key":"10.1016\/j.bcp.2024.116316_b0105","first-page":"1138","article-title":"Use of peptide libraries to map the substrate specificity of a peptide-modifying enzyme: a 13 residue consensus peptide specifies biotinylation in Escherichia coli","volume":"11","author":"Schatz","year":"1993","journal-title":"Biotechnology (N Y)."},{"key":"10.1016\/j.bcp.2024.116316_b0110","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1158\/1535-7163.MCT-15-0897","article-title":"Plk1 inhibitors in cancer therapy: From laboratory to clinics","volume":"15","author":"Gutteridge","year":"2016","journal-title":"Mol Cancer Ther."},{"key":"10.1016\/j.bcp.2024.116316_b0115","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.tranon.2016.10.003","article-title":"PLK1, A Potential Target for Cancer Therapy","volume":"10","author":"Liu","year":"2017","journal-title":"Transl Oncol."},{"key":"10.1016\/j.bcp.2024.116316_b0120","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1126\/science.1079079","article-title":"Proteomic screen finds pSer\/pThr-binding domain localizing Plk1 to mitotic substrates","volume":"299","author":"Elia","year":"2003","journal-title":"Science."},{"key":"10.1016\/j.bcp.2024.116316_b0125","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.ajhg.2012.03.012","article-title":"PSORS2 is due to mutations in CARD14","volume":"90","author":"Jordan","year":"2012","journal-title":"Am J Hum Genet."},{"key":"10.1016\/j.bcp.2024.116316_b0130","doi-asserted-by":"crossref","first-page":"35354","DOI":"10.1074\/jbc.M806258200","article-title":"Regulation of I(kappa)B kinase complex by phosphorylation of (gamma)-binding domain of I(kappa)B kinase (beta) by Polo-like kinase 1","volume":"283","author":"Higashimoto","year":"2008","journal-title":"J Biol Chem."},{"key":"10.1016\/j.bcp.2024.116316_b0135","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1091\/mbc.e09-08-0715","article-title":"The scaffold protein TANK\/I-TRAF inhibits NF-kappaB activation by recruiting polo-like kinase 1","volume":"21","author":"Zhang","year":"2010","journal-title":"Mol Biol Cell."},{"key":"10.1016\/j.bcp.2024.116316_b0140","doi-asserted-by":"crossref","first-page":"36841","DOI":"10.1074\/jbc.M313681200","article-title":"Polo-like kinase-1 is required for bipolar spindle formation but is dispensable for anaphase promoting complex\/Cdc20 activation and initiation of cytokinesis","volume":"279","author":"Van Vugt","year":"2004","journal-title":"J Biol Chem."},{"key":"10.1016\/j.bcp.2024.116316_b0145","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/nature07613","article-title":"Casein kinase 1alpha governs antigen-receptor-induced NF-kappaB activation and human lymphoma cell survival","volume":"458","author":"Bid\u00e8re","year":"2009","journal-title":"Nature."},{"key":"10.1016\/j.bcp.2024.116316_b0150","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.celrep.2019.09.040","article-title":"MALT1 Phosphorylation Controls Activation of T Lymphocytes and Survival of ABC-DLBCL Tumor Cells","volume":"29","author":"Gehring","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.bcp.2024.116316_b0155","doi-asserted-by":"crossref","first-page":"25277","DOI":"10.1074\/jbc.C300126200","article-title":"Identification of a consensus motif for Plk (Polo-like kinase) phosphorylation reveals Myt1 as a Plk1 substrate","volume":"278","author":"Nakajima","year":"2003","journal-title":"J Biol Chem."},{"key":"10.1016\/j.bcp.2024.116316_b0160","doi-asserted-by":"crossref","first-page":"9365","DOI":"10.3390\/ijms21249365","article-title":"UBAC1\/KPC2 Regulates TLR3 Signaling in Human Keratinocytes through Functional Interaction with the CARD14\/CARMA2sh-TANK Complex","volume":"21","author":"Mazzone","year":"2020","journal-title":"Int J Mol Sci."},{"key":"10.1016\/j.bcp.2024.116316_b0165","doi-asserted-by":"crossref","first-page":"e116062","DOI":"10.1371\/journal.pone.0116062","article-title":"The Dishevelled, EGL-10 and pleckstrin (DEP) domain-containing protein DEPDC7 binds to CARMA2 and CARMA3 proteins, and regulates NF-\u03baB activation","volume":"9","author":"D'Andrea","year":"2014","journal-title":"PLoS One."},{"key":"10.1016\/j.bcp.2024.116316_b0170","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.3390\/ijms18122581","article-title":"The E3 Ubiquitin Ligase RNF7 Negatively Regulates CARD14\/CARMA2sh Signaling","volume":"18","author":"Telesio","year":"2017","journal-title":"Int J Mol Sci."},{"key":"10.1016\/j.bcp.2024.116316_b0175","doi-asserted-by":"crossref","first-page":"e2627","DOI":"10.1038\/cddis.2017.51","article-title":"CARMA2sh and ULK2 control pathogen-associated molecular patterns recognition in human keratinocytes: psoriasis-linked CARMA2sh mutants escape ULK2 censorship","volume":"8","author":"Scudiero","year":"2017","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bcp.2024.116316_b0180","doi-asserted-by":"crossref","first-page":"4041","DOI":"10.1038\/s41467-018-06573-8","article-title":"Molecular architecture and regulation of BCL10-MALT1 filaments","volume":"9","author":"Schlauderer","year":"2018","journal-title":"Nat Commun."},{"key":"10.1016\/j.bcp.2024.116316_b0185","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.devcel.2015.03.024","article-title":"Mitotic Control of Planar Cell Polarity by Polo-like Kinase 1","volume":"33","author":"Shrestha","year":"2015","journal-title":"Dev Cell."},{"key":"10.1016\/j.bcp.2024.116316_b0190","doi-asserted-by":"crossref","first-page":"5180","DOI":"10.1038\/onc.2012.22","article-title":"Cyclin E drives human keratinocyte growth into differentiation","volume":"31","author":"Freije","year":"2012","journal-title":"Oncogene."},{"key":"10.1016\/j.bcp.2024.116316_b0195","doi-asserted-by":"crossref","first-page":"e268","DOI":"10.1038\/emm.2016.97","article-title":"Integrated computational approach to the analysis of RNA-seq data reveals new transcriptional regulators of psoriasis","volume":"48","author":"Zolotarenko","year":"2016","journal-title":"Exp Mol Med."},{"key":"10.1016\/j.bcp.2024.116316_b0200","doi-asserted-by":"crossref","first-page":"196","DOI":"10.2340\/00015555-3066","article-title":"The Keratinocyte Transcriptome in Psoriasis: Pathways Related to Immune Responses, Cell Cycle and Keratinization","volume":"99","author":"Pasquali","year":"2019","journal-title":"Acta Derm Venereol."},{"key":"10.1016\/j.bcp.2024.116316_b0205","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.3390\/biomedicines10082008","article-title":"CARD14 Signalling Ensures Cell Survival and Cancer Associated Gene Expression in Prostate Cancer Cells","volume":"10","author":"Vanneste","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.bcp.2024.116316_b0210","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.21873\/anticanres.14150","article-title":"Knockdown of CARD14 Inhibits Cell Proliferation and Migration in Breast Cancer Cells","volume":"40","author":"Lim","year":"2020","journal-title":"Anticancer Res."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295224002995?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295224002995?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,13]],"date-time":"2024-11-13T00:18:03Z","timestamp":1731457083000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295224002995"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":42,"alternative-id":["S0006295224002995"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2024.116316","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Polo-like kinase 1 (PLK1) is a novel CARD14-binding protein in keratinocytes","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2024.116316","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116316"}}